000			02046cam a2200409 a 4500
999			_c58001 _d58001
001			17205082
003			OSt
005			20170115150225.0
008			120305s2012 flua b 001 0 eng
010			_a 2012009446
020			_a9781439845677 (hardback : alk. paper)
035			_a(DNLM)101579512
040			_aDNLM/DLC _cDLC _dDLC
041			_aeng
042			_apcc
050	0	0	_aRA1238 _b.G333 2012
060	1	0	_aQV 771
082	0	0	_a615.704 _223 _bG S
100	1		_aGad, Shayne C., _d1948-
245	1	0	_aSafety Pharmacology In Pharmaceutical Development : _bApproval And Post Marketing Surveillance / _cShayne C. Gad.
250			_a2nd ed.
260			_aBoca Raton, FL : _bCRC Press, _cc2012.
265			_aالمكتبة الاكاديمية
300			_axv, 197 P. : _bill. ; _c24 cm.
500			_aسيد التونسي / كتب كلية الصيدلة
500			_aRev. ed. of: Safety pharmacology in pharmaceutical development and approval. c2004.
504			_aIncludes bibliographical references and index.
520			_a"This book covers the regulatory required evaluation and study of the potentially adverse pharmacological effects of new drugs, from the general regulatory requirements to the specific studies that must be done and how they are performed and interpreted. Based on more than 30 years of direct experience, the author describes tricks and practical insights for making studies work and understanding why they don't. The second edition includes current regulations (US FDA and international especially Europe and Japan) and updated test methods, interpretation, and science"--Provided by publisher.
650	1	7	_aDrug Evaluation, Preclinical.
650	2	7	_aDrug Approval.
650	2	7	_aProduct Surveillance, Postmarketing.
650	2	7	_aToxicity Tests.
700	1		_aGad, Shayne C., _d1948- _tSafety pharmacology in pharmaceutical development and approval.
906			_a7 _bcbc _corignew _d1 _eecip _f20 _gy-gencatlg
942			_2ddc _cBK
955			_apc22 2005-01-06 to ASCD _cjc41 2005-01-07